1. Available at: http://www.mefmaction.net/MECFSFM/Articles/Treatment/GlutathioneDeficiency/tabid/236/Default.aspx. Accessed November 25, 2010
2. Available at: http://www.chiro.org/nutrition/FULL/Recognizing_Drug_Induced_Nutrient_Depletion.shtml. Accessed November 25, 2010.
3. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci. 2006 Jan;89(1):31-41.
4. Fitzgerald GA. Coxibs and cardiovascular disease. N Engl J Med. 2004 Oct 21;351(17):1709-11.
5. Oates JA, FitzGerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ 2nd. Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med. 1988 Sep 15;319(11):689-98.
6. Fischer JH, Knupfer P. High-dosage aprotinin (Trasylol) therapy--is it safe for the kidney? Langenbecks Arch Chir. 1983;360(4):241-9.
7. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm142740.htm. Accessed March 15, 2011.
8. Sundt TM 3rd, Kouchoukos NT, Saffitz JE, Murphy SF, Wareing TH, Stahl DJ. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann Thorac Surg. 1993 Jun;55(6):1418-24.
9. Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007 Feb 7;297(5):471-9.
10. Available at: http://www.cbsnews.com/stories/2008/02/14/60minutes/main3831900.shtml. Accessed December 6, 2010.
11. Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006 Jan 26;354(4):353-65.
12. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108592.htm. Accessed November 30, 2010.
13. Available at: http://www.investor.bayer.de/en/news/archive/investor-news-2006/investor news/showNewsItem/669/1170082441/9c4ca18b75/. Accessed November 30, 2010.
14. Available at: http://www.investor.bayer.de/en/news/archive/investor-news-2006/investor-news/showNewsItem/673/1168957317/5620356922/. Accessed November 30, 2010.
15. Available at: http://www.corpwatch.org/article.php?id=14185. Accessed December 2, 2010.
16. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm142736.htm. Accessed December 2, 2010.
17. Available at: http://www.washingtonpost.com/wp-dyn/content/article/2008/05/14/AR2008051401658.html. Accessed December 2, 2010.
18. Available at: http://www.bayer.ca/files/Trasylol,%20BART,%20November%205,%20FINAL,%20Release.pdf. Accessed December 2, 2010.
19. Available at: http://www.investor.bayer.de/en/news/archive/investor-news-2007/investor-news/showNewsItem/868/1201512120/450afb010b. Accessed December 2, 2010.
20. Available at: http://www.fda.gov/downloads/NewsEvents/Newsroom/MediaTranscripts/UCM122284.pdf. Accessed December 2, 2010.
21. Available at: http://www.consumeraffairs.com/news04/2008/05/fda_trayslol.html. Accessed December 6, 2010.
22. Available at: http://articles.latimes.com/2006/oct/14/business/fi-bayer14. Accessed March 15, 2011.
23. Faloon W. FDA threatens to raid cherry orchards. Life Extension Magazine. 2006 Mar;12(3): 7-11.
24. Faloon W. FDA says walnuts are illegal drugs. Life Extension Magazine. Publication pending.
25. Available at: http://www.drugwatch.com/trasylol/side-effects.php. Accessed December 6, 2010.
26. Available at: http://www.fda-reports.com/Trasylol.html. Accessed December 9, 2010.
27. Available at: http://www.adrugrecall.com/trasylol/kidney-failure.html. Accessed December 10, 2010.
28. Available at: http://doublecheckmd.com/EffectsDetail.do?dname=Trasylol&sid=1439&eid=3076. Accessed December 10, 2010.
29. Available at: http://www.kcrlegal.com/trasylol.aspx. Accessed December 13, 2010.
30. Available at: http://arthritis.webmd.com/news/20050407/bextra-taken-off-market-celebrex-gets-warning. Accessed December 15, 2010.
31. Medications side effects. Life Extension Magazine. 2003 Mar.
32. Available at: http://www.naturalnews.com/030111_drug_companies_illegal.html. Accessed December 17, 2010
33. Loewenberg S. US FDA feels the heat from Congressional hearings. Lancet. 2008 May 10;371(9624):1565-6.
34. Available at: http://projects.publicintegrity.org/rx/report.aspx?aid=723. Accessed December 17, 2010. |